The cardiovascular clinical trials global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Cardiovascular Clinical Trials Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The cardiovascular clinical trials market size has grown strongly in recent years. It will grow from $4.99 billion in 2023 to $5.34 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to increased myocardial infarction, regulatory environment, increased disease burden, advancements in genomics, and increased demand for new drug development.
The cardiovascular clinical trials market size is expected to see strong growth in the next few years. It will grow to $7.03 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to an aging population, emerging markets, precision medicine, digital health technologies, and a focus on patient-centric trials. Major trends in the forecast period include increased collaborations, technological advancements, product innovations, new product developments, and the launch of generic versions of combination drugs.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/cardiovascular-clinical-trials-global-market-report
Scope Of Cardiovascular Clinical Trials Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Cardiovascular Clinical Trials Market Overview
Market Drivers –
The growing incidence of cardiovascular diseases is expected to drive the growth of the cardiovascular clinical trials market going forward. Cardiovascular disease refers to a group of conditions affecting the heart and blood vessels, including coronary artery disease, heart failure, and stroke. There is an increased incidence of cardiovascular diseases due to various factors, such as sedentary lifestyles, unhealthy diets, smoking, obesity, high blood pressure, diabetes, and genetic predispositions. Cardiovascular clinical trials help in discovering and validating new drugs that can more effectively manage risk factors such as hypertension, high cholesterol, and diabetes, which are significant contributors to CVDs. For instance, in May 2023, according to the Centers for Disease Control And Prevention, a US-based governmental organization, the percentage of coronary heart disease in adults aged 18 and over in 2020 was 4.6%, which increased to 4.9% in 2021. Therefore, the growing incidence of cardiovascular diseases is driving the growth of the cardiovascular clinical trials market.
Market Trends –
Major companies operating in the cardiovascular clinical trials market are focused on adopting strategic partnerships, such as contract research organization (CRO) partnerships, to expand their distribution networks and reach a wider customer base. A CRO partnership plays a crucial role in the clinical research industry and involves collaborations between different types of companies to provide specialized services and support for various aspects of clinical trials and research. For instance, in September 2023, Cereno Scientific AB, a Sweden-based biopharmaceutical company, collaborated with Clinical Trial Consultants (CTC), a Sweden-based full-service CRO with a focus on clinical conduct, to conduct a Phase I study for CS014, a histone deacetylase inhibitor aimed at preventing arterial and venous thrombosis. CTC will also assist with Phase I preparation processes such as study protocol development and the clinical trial application process for the study, which will be conducted in Sweden. This first-in-human Phase I trial is scheduled to begin in the first half of 2024. This collaboration signifies a significant step in advancing research on cardiovascular health.
The cardiovascular clinical trials market covered in this report is segmented –
1) By Phase: Phase I, Phase II, Phase III, Phase IV
2) By Study Design: Interventional, Observational, Expanded Access
3) By Indication : Acute Coronary Syndrome, Coronary Artery Disease, Ischemic Heart Disease, Pulmonary Arterial Hypertension, Stroke, Cardiac Arrhythmias, Heart Failure, Other Indications
Get an inside scoop of the cardiovascular clinical trials market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15532&type=smp
Regional Insights –
North America was the largest region in the cardiovascular clinical trials market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the cardiovascular clinical trials market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., AstraZeneca PLC, Novartis AG, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Merck & Co. Inc., Baxter International Inc., IQVIA Holdings Inc., SGS S.A., PPD Inc., WuXi AppTec Co. Ltd., Caidya, Syneos Health Inc., Charles River Laboratories International Inc., Sanofi, ICON plc, Medpace Holdings Inc., Cardiovascular Clinical Sciences., ProRelix Services LLP, Worldwide Clinical Trials
Table of Contents
1. Executive Summary
2. Cardiovascular Clinical Trials Market Report Structure
3. Cardiovascular Clinical Trials Market Trends And Strategies
4. Cardiovascular Clinical Trials Market – Macro Economic Scenario
5. Global Cardiovascular Clinical Trials Market Size and Growth
.
.
.
32. Global Cardiovascular Clinical Trials Market Competitive Benchmarking
33. Global Cardiovascular Clinical Trials Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Cardiovascular Clinical Trials Market
35. Cardiovascular Clinical Trials Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
